FDA Inspection 1265805 — Northwestern Medicine

Northwestern Medicine — FEI 3004743924

The FDA completed an inspection of Northwestern Medicine on April 2, 2025 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 2, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Chicago, IL (United States)